CP Reports Store
Current Partnering is the market-leading publisher of pharmaceutical and biotechnology dealmaking intelligence reports covering licensing agreements, collaboration agreements, co-development deals, M&A transactions, strategic alliances and partnering activity across the life sciences industry.
Our reports provide detailed analysis of real-world deal structures and financial terms, including upfront payments, milestone payments, royalty rates, equity investments and option-based deal mechanisms. Drawing on thousands of disclosed agreements, the reports enable business development and licensing professionals to benchmark comparable transactions and understand how partnerships are structured across therapeutic areas, technologies and company types.
Beyond financial terms, Current Partnering tracks key contractual provisions including exclusivity arrangements, geographic and territorial rights, regional licensing structures, development and commercialization responsibilities, co-promotion rights, manufacturing rights, intellectual property provisions and rights allocation between partners. This enables users to evaluate not only deal value but also how strategic control, risk and commercial opportunity are distributed between parties.
Coverage spans a broad range of therapeutic areas and technologies, including oncology, immunology, rare diseases, cell therapy, gene therapy, antibody-drug conjugates (ADCs), RNA therapeutics, vaccines and precision medicine.
Reports are widely relied upon globally by business development, licensing, corporate strategy, competitive intelligence and executive leadership teams to identify partners, benchmark transactions and support dealmaking decisions with real-world market evidence.
Browse our deal reports by: Deal Structure | Therapy | Technology | Development Stage | Industry | Annual Subscriptions
-
Cancer Diagnostic Collaboration and Licensing Deals 2018-2026May 2026$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2026
Learn More -
Gene Therapy Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Diagnostic Imaging Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Stem Cell Collaboration and Licensing Deals 2010-2026May 2026$3,995.00Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2026
Learn More -
Medical Device Collaboration and Licensing Deals 2016-2026May 2026$4,995.00Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Microbiome Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Microbiome Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Genomic Collaboration and Licensing Deals 2018-2026May 2026$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2026
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More
